Silo Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Silo Pharma's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $72,102. The net income raised on -$3,700,683 and profit margin reached -5133%. Total operating expenses were $3,916,018.

Profit Margin

Silo Pharma, Inc. (NASDAQ:SILO): Profit margin
2014 -107.11K -376.54K 351.54%
2015 -145.18K -409.49K 282.05%
2016 -669.48K -1.11M 166.24%
2017 847.40K 356.53K 42.07%
2018 0 -969.46K
2019 40.56K -1.04M -2583.47%
2020 40.92K -3.12M -7648.18%
2021 71.26K 3.90M 5477.86%
2022 72.10K -3.90M -5420.86%
2023 72.10K -3.70M -5132.57%

SILO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
72.10K72.10K71.26K40.92K40.56K0847.40K-669.48K-145.18K-107.11K
Cost of revenue
5.83K5.83K5.00K176.12K27.38K0000-127.67K
Gross profit
66.26K66.26K66.26K-135.20K13.18K0847.40K-669.48K-145.18K20.56K
Operating exp.
Research and development
845.09K1.28M693.91K88.8K63.46K00000
Selling and marketing
0-1.26M00000000
Total operating expenses
3.91M3.71M2.95M2.27M927.64K459.83K490.87K443.49K264.31K269.43K
Operating income
-3.85M-3.64M-2.74M-2.57M-930.40K-594.24K-470.38K-393.65K-217.17K-248.87K
Other income (expenses), net
224.50K-259.73K6.92M-464.55K-82.89K-513.85K826.92K-719.31K-192.32K0
Income before tax
-3.63M-3.90M4.18M-3.03M-1.01M-969.46K356.53K-1.11M-409.49K-376.54K
Income tax expense
01.16K24.87K92.34K34.79K-513.85K-62.91K000
Net income
-3.70M-3.90M3.90M-3.12M-1.04M-969.46K356.53K-1.11M-409.49K-376.54K
Earnings per share
Basic EPS
-1.2-1.712.06-2.37-2.23-0.990.5-1.11-0.4-0.39
Diluted EPS
-1.2-1.712.03-2.37-2.23-0.990.5-1.11-0.4-0.39
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source